Literature DB >> 33420030

Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis.

Xu Wang1,2, Li-Peng Hu1, Wei-Ting Qin1, Qin Yang1, De-Yu Chen2, Qing Li1, Kai-Xia Zhou1, Pei-Qi Huang1, Chun-Jie Xu1, Jun Li1, Lin-Li Yao1, Ya-Hui Wang1, Guang-Ang Tian1, Jian-Yu Yang3, Min-Wei Yang3, De-Jun Liu3, Yong-Wei Sun4, Shu-Heng Jiang5, Xue-Li Zhang6, Zhi-Gang Zhang7.   

Abstract

The immunosuppressive microenvironment that is shaped by hepatic metastatic pancreatic ductal adenocarcinoma (PDAC) is essential for tumor cell evasion of immune destruction. Neutrophils are important components of the metastatic tumor microenvironment and exhibit heterogeneity. However, the specific phenotypes, functions and regulatory mechanisms of neutrophils in PDAC liver metastases remain unknown. Here, we show that a subset of P2RX1-negative neutrophils accumulate in clinical and murine PDAC liver metastases. RNA sequencing of murine PDAC liver metastasis-infiltrated neutrophils show that P2RX1-deficient neutrophils express increased levels of immunosuppressive molecules, including PD-L1, and have enhanced mitochondrial metabolism. Mechanistically, the transcription factor Nrf2 is upregulated in P2RX1-deficient neutrophils and associated with PD-L1 expression and metabolic reprogramming. An anti-PD-1 neutralizing antibody is sufficient to compromise the immunosuppressive effects of P2RX1-deficient neutrophils on OVA-activated OT1 CD8+ T cells. Therefore, our study uncovers a mechanism by which metastatic PDAC tumors evade antitumor immunity by accumulating a subset of immunosuppressive P2RX1-negative neutrophils.

Entities:  

Year:  2021        PMID: 33420030     DOI: 10.1038/s41467-020-20447-y

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  57 in total

1.  Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer.

Authors:  Alvin P Makohon-Moore; Ming Zhang; Johannes G Reiter; Ivana Bozic; Benjamin Allen; Deepanjan Kundu; Krishnendu Chatterjee; Fay Wong; Yuchen Jiao; Zachary A Kohutek; Jungeui Hong; Marc Attiyeh; Breanna Javier; Laura D Wood; Ralph H Hruban; Martin A Nowak; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nat Genet       Date:  2017-01-16       Impact factor: 38.330

2.  [Ovine luteinizing hormone (LH). I. Yield in apparently homogeneous state. Physicochemical and biological study].

Authors:  M Jutisz; C Courte
Journal:  Gen Comp Endocrinol       Date:  1968-12       Impact factor: 2.822

Review 3.  Recent progress in pancreatic cancer.

Authors:  Christopher L Wolfgang; Joseph M Herman; Daniel A Laheru; Alison P Klein; Michael A Erdek; Elliot K Fishman; Ralph H Hruban
Journal:  CA Cancer J Clin       Date:  2013-07-15       Impact factor: 508.702

Review 4.  Extracellular ATP and P2 purinergic signalling in the tumour microenvironment.

Authors:  Francesco Di Virgilio; Alba Clara Sarti; Simonetta Falzoni; Elena De Marchi; Elena Adinolfi
Journal:  Nat Rev Cancer       Date:  2018-10       Impact factor: 60.716

Review 5.  Targeting immunosuppressive adenosine in cancer.

Authors:  Dipti Vijayan; Arabella Young; Michele W L Teng; Mark J Smyth
Journal:  Nat Rev Cancer       Date:  2017-10-23       Impact factor: 60.716

Review 6.  Neutrophils in cancer: neutral no more.

Authors:  Seth B Coffelt; Max D Wellenstein; Karin E de Visser
Journal:  Nat Rev Cancer       Date:  2016-06-10       Impact factor: 60.716

7.  Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer.

Authors:  Valeria Quaranta; Carolyn Rainer; Sebastian R Nielsen; Meirion L Raymant; Muhammad S Ahmed; Dannielle D Engle; Arthur Taylor; Trish Murray; Fiona Campbell; Daniel H Palmer; David A Tuveson; Ainhoa Mielgo; Michael C Schmid
Journal:  Cancer Res       Date:  2018-05-22       Impact factor: 12.701

Review 8.  Extracellular purines, purinergic receptors and tumor growth.

Authors:  F Di Virgilio; E Adinolfi
Journal:  Oncogene       Date:  2016-06-20       Impact factor: 9.867

9.  Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer.

Authors:  Jérémy Nigri; Rémi Samain; Delphine Goehrig; Zhichong Wu; Paola Cappello; Gaëlle Gabiane; Xinyi Zhang; Yajie Zhao; In-San Kim; Marie Chanal; Roberta Curto; Valerie Hervieu; Christelle de La Fouchardière; Francesco Novelli; Pascale Milani; Richard Tomasini; Corinne Bousquet; Philippe Bertolino; Ana Hennino
Journal:  Gut       Date:  2018-11-10       Impact factor: 23.059

10.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.

Authors:  Richard A Moffitt; Raoud Marayati; Elizabeth L Flate; Keith E Volmar; S Gabriela Herrera Loeza; Katherine A Hoadley; Naim U Rashid; Lindsay A Williams; Samuel C Eaton; Alexander H Chung; Jadwiga K Smyla; Judy M Anderson; Hong Jin Kim; David J Bentrem; Mark S Talamonti; Christine A Iacobuzio-Donahue; Michael A Hollingsworth; Jen Jen Yeh
Journal:  Nat Genet       Date:  2015-09-07       Impact factor: 38.330

View more
  16 in total

1.  NcRNAs-mediated P2RX1 expression correlates with clinical outcomes and immune infiltration in patients with breast invasive carcinoma.

Authors:  Yiyue Xu; Bing Zou; Bingjie Fan; Butuo Li; Jinming Yu; Linlin Wang; Jin Zhang
Journal:  Aging (Albany NY)       Date:  2022-05-18       Impact factor: 5.955

2.  Thrombospondin-2 acts as a bridge between tumor extracellular matrix and immune infiltration in pancreatic and stomach adenocarcinomas: an integrative pan-cancer analysis.

Authors:  Xingchen Liao; Wei Wang; Baoping Yu; Shiyun Tan
Journal:  Cancer Cell Int       Date:  2022-06-14       Impact factor: 6.429

3.  Development of a prognostic metabolic signature in stomach adenocarcinoma.

Authors:  Yu Gong; Siyuan Wu; Sen Dong; Shuai Chen; Gengdi Cai; Kun Bao; Haojun Yang; Yuwen Jiao
Journal:  Clin Transl Oncol       Date:  2022-03-30       Impact factor: 3.340

Review 4.  Neutrophil in the Pancreatic Tumor Microenvironment.

Authors:  Lin Jin; Hong Sun Kim; Jiaqi Shi
Journal:  Biomolecules       Date:  2021-08-07

Review 5.  Pancreatic cancer immune evasion mechanisms: the immunosuppressive role of P2RX1-negative neutrophils.

Authors:  Valentina Audrito
Journal:  Purinergic Signal       Date:  2021-03-30       Impact factor: 3.765

Review 6.  Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer.

Authors:  Hillary G Pratt; Kayla J Steinberger; Nicole E Mihalik; Sascha Ott; Thomas Whalley; Barbara Szomolay; Brian A Boone; Timothy D Eubank
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

7.  The insertion and dysregulation of transposable elements in osteosarcoma and their association with patient event-free survival.

Authors:  Chao Wang; Chun Liang
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.996

8.  Long noncoding RNA GSEC promotes neutrophil inflammatory activation by supporting PFKFB3-involved glycolytic metabolism in sepsis.

Authors:  Dadong Liu; Wen Sun; Danying Zhang; Zongying Yu; Weiting Qin; Yishu Liu; Kai Zhang; Jiangtao Yin
Journal:  Cell Death Dis       Date:  2021-12-14       Impact factor: 8.469

9.  An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma.

Authors:  Wenjing Zhang; Yuting Li; Juncheng Lyu; Fuyan Shi; Yujia Kong; Chao Sheng; Suzhen Wang; Qinghua Wang
Journal:  Cancer Sci       Date:  2022-01-07       Impact factor: 6.716

10.  C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.

Authors:  Baochi Ou; Jingjie Zhang; Yuan Liu; Xiaowei Yang; Xiaojun Xu; Yunwen Yan
Journal:  Cell Death Dis       Date:  2021-07-26       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.